These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15308276)

  • 1. Use of antibacterial agents in renal failure.
    Livornese LL; Slavin D; Gilbert B; Robbins P; Santoro J
    Infect Dis Clin North Am; 2004 Sep; 18(3):551-79, viii-ix. PubMed ID: 15308276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of antibacterial agents in renal failure.
    Gilbert B; Robbins P; Livornese LL
    Infect Dis Clin North Am; 2009 Dec; 23(4):899-924, viii. PubMed ID: 19909890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antibacterial agents in renal failure.
    Gilbert B; Robbins P; Livornese LL
    Med Clin North Am; 2011 Jul; 95(4):677-702, vii. PubMed ID: 21679787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial agents in renal failure.
    Livornese LL; Benz RL; Ingerman MJ; Santoro J
    Infect Dis Clin North Am; 1995 Sep; 9(3):591-614. PubMed ID: 7490435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antibacterial agents in renal failure.
    Livornese LL; Slavin D; Benz RL; Ingerman MJ; Santoro J
    Infect Dis Clin North Am; 2000 Jun; 14(2):371-90, ix. PubMed ID: 10829261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic dosing in patients with renal insufficiency or receiving dialysis.
    Cunha BA; Friedman PE
    Heart Lung; 1988 Nov; 17(6 Pt 1):612-6. PubMed ID: 3056882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosage adjustment of antiinfective therapy in patients with renal impairment.
    Eckhardt A; Borner K; Keller F; Zellner D
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):99-102. PubMed ID: 9088997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic dosing in slow extended daily dialysis.
    Mushatt DM; Mihm LB; Dreisbach AW; Simon EE
    Clin Infect Dis; 2009 Aug; 49(3):433-7. PubMed ID: 19580416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G; Carricajo A
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic use in patients with renal or hepatic failure].
    Ramón Azanza J; García E; Sádaba B; Manubens A
    Enferm Infecc Microbiol Clin; 2009 Dec; 27(10):593-9. PubMed ID: 19853975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic dosing in extended dialysis.
    Kielstein JT; Burkhardt O
    Clin Infect Dis; 2009 Dec; 49(12):1963; author reply 1964. PubMed ID: 19929396
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interest in therapeutic drug monitoring of the main antibiotics].
    Davani S; Muret P; Royer B; Hoen B; Kantelip JP
    Ann Biol Clin (Paris); 2002; 60(6):655-61. PubMed ID: 12446229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented renal clearance in the Intensive Care Unit: an illustrative case series.
    Udy AA; Putt MT; Shanmugathasan S; Roberts JA; Lipman J
    Int J Antimicrob Agents; 2010 Jun; 35(6):606-8. PubMed ID: 20307958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial agents in pediatric cancer patients with hepatic or renal impairment].
    Kolve H; Silling G; Ritter J; Groll AH
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S150-64. PubMed ID: 16288361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring antibiotic therapy in the newborn infant.
    Craft JC
    Clin Perinatol; 1981 Jun; 8(2):263-72. PubMed ID: 7273587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside nephrotoxicity.
    Swan SK
    Semin Nephrol; 1997 Jan; 17(1):27-33. PubMed ID: 9000547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of antimicrobials in renal insufficiency].
    Pascual J; Ortuño J
    Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):97-107. PubMed ID: 2098148
    [No Abstract]   [Full Text] [Related]  

  • 18. Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective.
    Pea F; Poz D; Viale P; Pavan F; Furlanut M
    J Antimicrob Chemother; 2006 Aug; 58(2):380-6. PubMed ID: 16735422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of antibiotic dosage adjustments in patients with renal impairment: elements for success.
    Patel N; Scheetz MH; Drusano GL; Lodise TP
    J Antimicrob Chemother; 2010 Nov; 65(11):2285-90. PubMed ID: 20736235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.